Product Program year 2025 Source: CMS Open Payments

Xience V

Device Vascular

PDI 08717648064470

Open in the dashboard

General payments

$497,030

959 payments

Research payments

$168,730

117 payments

Through program year 2025, $497,030 in general payments and $168,730 in research payments were reported against Xience V (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 Research $2,750 3
2024 General $222,013 139
2023 General $108,536 241
2023 Research $137,865 94
2022 General $166,481 579
2022 Research $28,115 20

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $497,030 959 payments
Top recipients General payments · program year 2024
  1. Steven Marx Cardiovascular Disease · New York, NY $31,250 14% · 24 payments
  2. Beth Israel Deaconess Medical Center Teaching hospital · MA $31,238 14% · 1 payment
  3. Ozgen Dogan Cardiovascular Disease · Brooklyn, NY $24,500 11% · 16 payments
  4. Daniel Asemota Interventional Cardiology · Los Angeles, CA $18,182 8% · 1 payment
  5. Mark Connolly Thoracic Surgery (Cardiothoracic Vascular Surgery) · Paterson, NJ $16,750 8% · 9 payments

The top 5 of 28 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Cardiovascular Disease Internal Medicine $85,512 50% · 7 practitioners
  2. Interventional Cardiology Internal Medicine $62,056 37% · 11 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $16,750 10% · 1 practitioner
  4. Neurology Psychiatry & Neurology $2,000 1% · 1 practitioner
  5. Nurse Practitioner, Pediatrics, Critical Care Nurse Practitioner $1,705 1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $132,432 60% · 9 recipients
  2. Massachusetts $35,238 16% · 3 recipients
  3. Michigan $22,763 10% · 3 recipients
  4. Pennsylvania $18,456 8% · 2 recipients
  5. Illinois $3,051 1% · 1 recipient

The top 5 of 13 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

959 general · 117 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record